Subjects have signed the informed consent document
Subjects with unruptured infrarenal AAA who are assessed by the Investigator to be eligible for endovascular Abdominal Aortic Aneurysm Repair with the trial devices.
Patient must be able and willing to comply with all required follow-up exams.
You may not be if
Currently participating in another trial where the primary endpoint has not been reached yet.
Known allergy to any of the device components
Pregnant (females of childbearing potential only)
Known connective tissue disorders
Known active infection
Subjects with pre-existing EVAR, i.e., in need of repair/intervention of a previously failed EVAR.
Patient has other medical, social, or psychological conditions that, in the opinion of the investigator, preclude them from receiving the pre-treatment, required treatment, and post-treatment procedures and evaluations.
Clareo Health | JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization
